Gegeneraliseerde angststoornis - GGZ-richtlijnen

5
5
10
15
20
25
30
35
40
45
50
Literatuur
1. Allgulander, C Dahl, AA., Austin, C., Morris, P.L .P, Sogaard, J.A. Fayyad, R et al (2004) Efficacy of
sertraline in a l2-week trial for generalized anxiety disorder. American Journal of Psychiatry 161, 1642-1649.
2. Allgulander, C, Florea, T, Trap Huusom A K. (2005). Prevention of relapse in generalized anxiety disorder by
escitalopram treatment. International Journal of Neuropsychopharnacology, 9, 1-11.
3. Allgulander C, Hackett D, Salinas E. Venlafaxine extended release in the treatment of generalized anxiety
disorder, 24 week placebo-controlled dose-ranging study. Br J Psychiatry 2001; 179: 15-22.
4. Baldwin DS, Polkinghorn C. Evidence-based pharmacotherapy of generalized anxiety disorder. 2005. New
York, NY,US: Cambridge University Press.
5. BaII, SG, Kuhn, A, Wall, D, Shekhar A, Goddard A W (2005) Selective serotonin reuptake inhibitor treatment
for generalized anxiety disorder: A double-blind, prospective comparison between paroxerine and sertraline.
Journal of Clinical Psychiatry, 66, 94-99.
6. Bielski R, Bose A, Chang CC (2005). A double-blind comparison of escitalopram and paroxetine in the longterm
treatment of generalized anxiety disorder. Annals of Clinical Psychiatry, 17, 65-69.
7. DahI AA, Ravindran A, Allgulander C, Kutcher S,P, Austin C, Burt T (2005). Sertraline in generalized anxiety
disorder: Efficacy in treating the psychic and somatic anxiety factors. Acta Psychiatrica Scandinavica, 111,
429—435.
8. Davidson JR, Bose A, Korotzer A, Zheng H. Escitalopram in the treatment of generalized anxiety
disorder: double-blind,placebo controlled, flexible-dose study. Depress Anxiety 2004;19(4):234-
40.
9. Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E. Efficacy of venlafaxine extended
release capsules in nondepressed outpatiënts with generalized anxiety disorder. 6-month randomized
controlled study. JAMA 2000; 283: 3082-3088.
10. Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E. Efficacy of venlafaxine extended
release capsules in nondepressed outpatiënts with generalized anxiety disorder. 6-month randomized
controlled study. JAMA 2000; 283: 3082-3088.
11. Hoehn-Saric R, McLoud DR, Zimmerli WD. Differential effects of alprazolam and imipramine in generalized
anxiety disorder: somatic versus psychic symptoms. J Clin Psychiatry 1988; 49: 293-301.
12. Kapczinski F, Lima MS, Souza JS, Cunha A, Schmitt R. Antidepressants for generalized anxiety disorder.
Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD003592. DOI:
10.1002/14651858.CD003592.
13. Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyngar MK. Paroxetine in the
treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin
Psychiatry 2001; 62: 350-357
14. Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyngar MK. Paroxetine in the
treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin
Psychiatry 2001; 62: 350-357
15. Rocca P, Fonzo V, Scotta M, Zanalda E, Ravizza L. Paroxetine efficacy in the treatment of generalized
anxiety disorder. Acta Psychiatrica Scandinavica 1997; 95: 444-450.
16. Rickels K, Zaninelli R, McCafferty J., Bellew K, lyengar,M, Sheehan D. (2003). Paroxetine treatment of
generalized anxiety disorder: A double-blind placebo-controlled study. Am Journal of Psychiatry, 160: 749-
56.
17. Rickels K, Pollack MH, Sheehan DV, Haskins JT. Efficacy of extended-release venlafaxine in nondepressed
outpatiënts with generalized anxiety disorder. Am J Psychiatry 2000; 157: 968-974.
18. Rickels K, Downing R, Schweizer E, et al. Antidepressants for the treatment of generalized anxiety disorder:
a placebo-controlled comparison of imipramine, trazodone and diazepam. Arch Gen Psychiatry 1993; 50:
884-895.
19. Stocchi F, Nordera G, Jokinen R, Lepola U, Bryson H, Hewett K, Iyengar M. (2003). Efficacy and tolerability
of paroxetine for the long-term treatment of generalized anxiety disorder.Journal of Clinical Psychiatry, 64:
250-258.